1. Melanoma Institute Australia, The University of Sydney, Mater Hospital, and Royal North Shore Hospital, Sydney, Australia;
2. Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel;
3. University of California, Los Angeles, Los Angeles, CA;
4. Hospital Clínic de Barcelona, Barcelona, Spain;
5. Aix-Marseille University, Hopital de la Timone, Marseille, France;
6. Université Lille, Centre Hospitalier Régional Universitaire de Lille, Lille, France;
7. University of California, San Francisco, San Francisco, CA;
8. Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia;
9. Chris O'Brien Lifehouse, Camperdown, Australia;
10. Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel;
11. The Royal Marsden Hospital, London, United Kingdom;
12. University of Manchester and the Christie NHS Foundation Trust, Manchester, United Kingdom;
13. Universitair Ziekenhuis Brussel, Brussels, Belgium;
14. Netherlands Cancer Institute, Amsterdam, Netherlands;
15. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;
16. The Angeles Clinic and Research Institute, Los Angeles, CA;
17. Merck & Co., Inc., Kenilworth, NJ;
18. Merck & Co., Inc., Kenilworth, NJ, US;
19. Merck & Co, Inc., Kenilworth, NJ;
20. Gustave Roussy Institute, Paris, France;